First patient with rare muscle disease treated with own stem cells
First patient with rare muscle disease treated with own stem cells 9 November 2025 Maastricht UMC+ has, for the first […]
treatment for mitochondrial disease
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d International Mito Patient (IMP) is delighted to welcome yesterday’s approval by
Watch our Webinar: The power of nutrition and mitochondrial diseases
Watch our Webinar: The power of nutrition and mitochondrial diseases As part of LHON Awareness Day, we hosted a powerful
From Advocacy to Access: Mito Community Celebrates FDA Milestone
Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug